期刊
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
卷 26, 期 2, 页码 261-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.iac.2006.02.001
关键词
-
Recombinant DNA technology has delivered the prospect of a new generation of preparations for allergen-specific immunotherapy. The first clinical studies with recombinant allergens have yielded encouraging results, suggesting that there is a good chance that such preparations will become available for use in the routine management of allergic disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据